Francesca Barone
Vermögen: 1 Mio $ am 31.08.2026
Vermögen: 1 Mio $ am 31.08.2026
Francesca Barone is currently Chief Scientific Officer at Candel Therapeutics, Inc. since 2022.
Former positions include Director-Laboratories at the Institute of Translational Medicine, Associate Professor at the University of Birmingham from 2010 to 2019, and Head-Experimental Medicine at Senda Biosciences, Inc. from 2019 to 2021.
Education includes doctorates from Sapienza University of Rome and King's College London.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.06.2026 | 77.362 ( 0,1 % ) | 1 Mio $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Corporate Officer/Principal | 01.11.2021 |
University of Birmingham
University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.12.2019 |
Institute of Translational Medicine | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
University of Birmingham
University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sapienza University of Rome
Sapienza University of Rome Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
King's College London
King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Health Technology |
Institute of Translational Medicine |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen